We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+13.87%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$19.2B
AUM Growth
+$2.27B
Cap. Flow
+$233M
Cap. Flow %
1.21%
Top 10 Hldgs %
23.73%
Holding
923
New
25
Increased
475
Reduced
375
Closed
12

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$53.8M
2
WTW icon
Willis Towers Watson
WTW
+$43.9M
3
CMCSA icon
Comcast
CMCSA
+$31.7M
4
UBS icon
UBS Group
UBS
+$30.6M
5
CAT icon
Caterpillar
CAT
+$29.8M

Top Sells

Rank Stock Value
1
ALC icon
Alcon
ALC
+$82.9M
2
AON icon
Aon
AON
+$48.6M
3
TT icon
Trane Technologies
TT
+$39.2M
4
DRI icon
Darden Restaurants
DRI
+$38M
5
LUV icon
Southwest Airlines
LUV
+$33M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 14.42%
3 Healthcare 13.44%
4 Consumer Discretionary 12.76%
5 Communication Services 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
776
Ionis Pharmaceuticals
IONS
$9.4B
$1.46M 0.01%
25,809
-19,110
-43% -$952K
UNF icon
777
Unifirst Corp
UNF
$5.25B
$1.46M 0.01%
6,880
-5,577
-45% -$1.06M
MRCY icon
778
Mercury Systems
MRCY
$6.52B
$1.44M 0.01%
16,401
-13,296
-45% -$1.01M
PRLB icon
779
Protolabs
PRLB
$2.13B
$1.44M 0.01%
9,406
-7,626
-45% -$1.08M
RYTM icon
780
Rhythm Pharmaceuticals
RYTM
$7.96B
$1.43M 0.01%
48,218
-39,089
-45% -$993K
TTC icon
781
Toro Company
TTC
$9.49B
$1.43M 0.01%
15,123
-12,260
-45% -$1.08M
IMO icon
782
Imperial Oil
IMO
$60.4B
$1.43M 0.01%
75,437
+2,857
+4% +$45.8K
AXNX
783
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.43M 0.01%
28,644
-23,220
-45% -$1.09M
NEU icon
784
NewMarket
NEU
$8.18B
$1.43M 0.01%
3,589
-2,908
-45% -$1.08M
ZNGA
785
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1.43M 0.01%
144,765
-117,360
-45% -$1.06M
DIN icon
786
Dine Brands
DIN
$452M
$1.43M 0.01%
24,613
+4,216
+21% +$256K
ICUI icon
787
ICU Medical
ICUI
$4.61B
$1.43M 0.01%
6,651
-5,391
-45% -$1.05M
SAFM
788
DELISTED
Sanderson Farms Inc
SAFM
$1.43M 0.01%
10,786
-8,743
-45% -$1.15M
MXL icon
789
MaxLinear
MXL
$6.8B
$1.42M 0.01%
+37,125
New +$1.08M
NWSA icon
790
News Corp Class A
NWSA
$15.4B
$1.42M 0.01%
78,875
-185
-0.2% -$2.98K
HLF icon
791
Herbalife
HLF
$1.29B
$1.41M 0.01%
29,376
+195
+0.7% +$9.41K
KURA icon
792
Kura Oncology
KURA
$850M
$1.41M 0.01%
43,192
-35,014
-45% -$1.23M
LBTYA icon
793
Liberty Global Class A
LBTYA
$3.6B
$1.41M 0.01%
58,164
+916
+2% +$20.4K
SLP icon
794
Simulations Plus
SLP
$371M
$1.4M 0.01%
19,526
-15,831
-45% -$1.05M
NDSN icon
795
Nordson
NDSN
$17.3B
$1.4M 0.01%
6,963
-5,292
-43% -$1.06M
LOPE icon
796
Grand Canyon Education
LOPE
$3.98B
$1.4M 0.01%
15,013
-12,172
-45% -$1.04M
CHE icon
797
Chemed
CHE
$7.22B
$1.39M 0.01%
2,611
-2,118
-45% -$1.04M
PEGA icon
798
Pegasystems
PEGA
$5.38B
$1.39M 0.01%
20,862
-16,910
-45% -$1.08M
DCPH
799
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.38M 0.01%
24,216
-19,631
-45% -$1.16M
MANH icon
800
Manhattan Associates
MANH
$11.4B
$1.37M 0.01%
13,056
-10,586
-45% -$1.04M

Similar funds

Aviva's Q4 2020 Portfolio in Review

As of Q4 2020, Aviva held 923 positions worth $19.2B, up 13% from $17B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 4%. Aviva opened 25 new positions and exited 12, leaving the 923-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Aviva's largest Q4 2020 buy was Valvoline: 871,000 shares worth $20.2M.
  • Aviva added most to Charter Communications in Q4 2020, an estimated $53.8M increase.
  • Aviva's biggest Q4 2020 reduction was Alcon, cutting an estimated $82.9M.
  • Aviva fully exited Aimco in Q4 2020, selling an estimated $3.69M.
  • Aviva's ten largest holdings make up 24% of its $19.2B portfolio in Q4 2020.
  • Aviva opened 25 new positions and closed 12 in Q4 2020.
  • Aviva's portfolio value rose 13% quarter-over-quarter to $19.2B.

Based on Aviva's 13F filing for Q4 2020, filed 10 Feb 2021.